This review examines the evolution, current status, and future potential of minimally invasive glaucoma surgeries (MIGS), a significant advancement in the treatment of glaucoma, a leading cause of irreversible blindness. MIGS offer a less invasive alternative to traditional glaucoma surgeries, primarily aimed at reducing intraocular pressure (IOP), minimizing tissue trauma, and providing a safer profile. Devices such as the Trabectome, iStent, and others have expanded the surgical toolkit, allowing for personalized, patient-centered care. Despite their advantages, MIGS face challenges such as efficacy in severe cases, long-term data, and accessibility. Ongoing research and technological innovations continue to refine their capabilities and applications, promising to further transform glaucoma management and patient outcomes. The review provides an in-depth analysis of MIGS, reflecting on their impact and contemplating future directions in this dynamically evolving field.This review examines the evolution, current status, and future potential of minimally invasive glaucoma surgeries (MIGS), a significant advancement in the treatment of glaucoma, a leading cause of irreversible blindness. MIGS offer a less invasive alternative to traditional glaucoma surgeries, primarily aimed at reducing intraocular pressure (IOP), minimizing tissue trauma, and providing a safer profile. Devices such as the Trabectome, iStent, and others have expanded the surgical toolkit, allowing for personalized, patient-centered care. Despite their advantages, MIGS face challenges such as efficacy in severe cases, long-term data, and accessibility. Ongoing research and technological innovations continue to refine their capabilities and applications, promising to further transform glaucoma management and patient outcomes. The review provides an in-depth analysis of MIGS, reflecting on their impact and contemplating future directions in this dynamically evolving field.